A278650 Share Price Performance
₩0
-2195.00 (-100.00%)
Price ₩0
Share Pricen/a
Is HLB bioStepLtd (KOSDAQ:278650) A Risky Investment?
Jan 23
HLB bioStep Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A278650 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
HLB bioStep Co.,Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -91.13
- 73.78%
- -10.77%
- 26.1%
About A278650
- Founded
- 2012
- Employees
- 150
- CEO
- WebsiteView website
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug development consulting and clinical trial services, and bioanalysis items. The company was formerly known as KNOTUS Co.,Ltd. HLB bioStep Co.,Ltd. was founded in 2012 and is headquartered in Incheon, South Korea.
